RT info:eu-repo/semantics/article
T1 Combination of BeGraft and Solaris stent grafts for the covered endovascular reconstruction of aortic bifurcation—BS-CERAB technique
A1 San Norberto García, Enrique María
A1 Revilla, Álvaro
A1 Brizuela Sanz, José Antonio
A1 Blanco Alonso, María Isabel del
A1 Flores, Ángel
A1 Taylor, James
K1 Cardiovascular system - Diseases
K1 Sistema cardiovascular - Enfermedades
K1 Blood-vessels - Diseases
K1 Vasos sanguíneos - Enfermedades
K1 Stents (Surgery)
K1 Angioplasty
K1 Angioplastia
K1 Coronary heart disease - Surgery
K1 Arterias coronarias - Enfermedades
K1 Heart - Diseases
K1 Corazón - Enfermedades
K1 Cardiology
K1 Clinical Medicine
K1 3205.01 Cardiología
K1 3207.04 Patología Cardiovascular
K1 3213.17 Cirugía Vascular
K1 3201 Ciencias Clínicas
AB Background: This study examines the impact of the use of the combination of BeGraft and Solaris stent grafts on the outcomes during the covered endovascular reconstruction of aortic bifurcation (BS-CERAB) technique and extension to the iliac arteries. Methods: Consecutive patients with aortoiliac occlusive disease who underwent endovascular treatment using BS-CERAB between January 2020 and December 2023 were included. Patient demographics, symptoms, lesion characteristics, and procedural and follow-up details were collected and analyzed. Perioperative complications and reinterventions were also identified. Results: A total of 42 patients met the inclusion criteria (32 men, 76.2%, median age 72 years, range 59–85). Indications for treatment were intermittent claudication (42.9%) and critical limb ischemia (57.1%). Procedure success was achieved in all cases. The median patient follow-up time was 14 months (1–36). One patient died at a 10-month follow-up due to lung cancer. The mean pre-operative ABI increased from 0.37 ± 0.19 before intervention to 0.71 ± 1.23 post-operatively at 12 months (p = 0.037). The estimated primary patency rates at 3, 6, and 12 months were 90.5%, 85.7%, and 81.0% and primary assisted patency rates were 90.5%, 90.5%, and 85.7%, respectively. Secondary patency was 95.2% at 3 and 6 months and 90.5% at a 12-month follow-up. Active cancer (p = 0.023, OR 2.12 95%CI 1.14–3.25) was a risk factor for restenosis. Conclusions: This mid-term experience shows that the CERAB technique using the combination of BeGraft and Solaris stents grafts, for the endovascular treatment of severe aortoiliac atherosclerotic disease, may allow an effective reconstruction of the aortic bifurcation and iliac arteries related to high-patency and lower-reintervention rates.
PB MDPI
SN 2077-0383
YR 2024
FD 2024
LK https://uvadoc.uva.es/handle/10324/70101
UL https://uvadoc.uva.es/handle/10324/70101
LA eng
NO Journal of Clinical Medicine, 2024, Vol. 13, Nº. 7, 1925
NO Producción Científica
DS UVaDOC
RD 22-nov-2024